Poly Medicure Limited
POLYMED
Rank in Stocks
#6419
Poly Medicure Limited (PML) specializes in the production and distribution of a... Poly Medicure Limited (PML) specializes in the production and distribution of a wide array of medical devices. Its extensive product portfolio encompasses a comprehensive range of infusion equipment, including IV cannulas, midline and arterial catheters, three-way stopcocks, various infusion sets (standard, safety winged, and measured volume), manifolds, extension lines, stylets/mandrins with luer locks, vial access spikes, central venous catheters, CVP manometers, needle-free connectors, pre-filled syringes, vascular access devices, and blood administration sets. The company also supplies diverse feeding solutions, such as nasogastric, infant, and gastro-duodenal feeding tubes, alongside umbilical catheters. Urology offerings include urine collection bags (with or without measured volume meters), Foley balloon catheters, irrigation sets, and general urine drainage catheters. For respiratory and anesthesia care, PML manufactures endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator and Bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. The company also provides oncology-specific products. Oxygen and respiratory therapy devices feature endobronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oropharyngeal airways, and various oxygen masks, including variable concentration, reservoir, fixed concentration, and aerosol therapy types. Its renal care segment comprises dialyzers, blood lines, complete dialysis systems, fistula needles, hemodialysis catheters, and peritoneal dialysis and transfusion sets. Surgical drainage products include closed wound suction units, underwater seal drainage systems, high-pressure vacuum bottles, Yankauer suction sets, and thoracic drainage catheters. For phlebotomy and blood diagnostics, PML supplies blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors. Blood bag systems are also available. Personal protective equipment (PPE) such as face shields and polymasks, along with viral transport medium kits, form part of its offering. Further miscellaneous medical disposables encompass insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. Established in 1995, the company is headquartered in New Delhi, India.
Share Price
$17.18
Last synced: 2026-11-09
Market Cap
$1.74B
Change (1 day)
0.67%
Change (1 year)
-26.33%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Poly Medicure Limited (POLYMED)
Category
Healthcare
Operating Margin for Poly Medicure Limited (POLYMED)
Operating Margin as of November 2026 TTM: 16.68%
According to Poly Medicure Limited's latest financial reports, its current operating margin (TTM) is 16.68%. At the end of 2025 the company had an operating margin of 46.46%.
Operating Margin history for Poly Medicure Limited from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 16.68% | -64.10% |
| 2025 | 46.46% | 3.43% |
| 2024 | 44.92% | 4.20% |
| 2023 | 43.11% | 2.96% |
| 2022 | 41.87% | -9.78% |
| 2021 | 46.41% | 1.93% |
| 2020 | 45.53% | 3.93% |
| 2019 | 43.81% | -5.07% |
| 2018 | 46.15% | 6.98% |
| 2017 | 43.14% | 3.48% |
| 2016 | 41.69% | -1.98% |
| 2015 | 42.53% | 66.59% |
| 2014 | 25.53% | 17.81% |
| 2013 | 21.67% | 63.05% |
| 2012 | 13.29% | -3.70% |
| 2011 | 13.80% | 7.90% |
| 2010 | 12.79% | 28.16% |
| 2009 | 9.98% | -25.96% |
| 2008 | 13.48% | -9.53% |
| 2007 | 14.90% | 6.96% |
| 2006 | 13.93% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -98.30% |
US
|
|
| 12.36% | -99.26% |
FR
|
|
| 9.83% | -99.41% |
US
|
|
| 31.11% | -98.13% |
JP
|
|
| 9.87% | -99.41% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Poly Medicure Limited's operating margin
What is Poly Medicure Limited's operating margin?
Poly Medicure Limited's operating margin is 16.68%, as of Nov 2026.
What was Poly Medicure Limited's operating margin in 2025?
In 2025, Poly Medicure Limited's operating margin was 46.46%, compared with 44.92% in 2024.
How has Poly Medicure Limited's operating margin changed since 2020?
From 2020 to 2025, Poly Medicure Limited's operating margin was highest in 2025 (46.46%) and lowest in 2022 (41.87%).
How does Poly Medicure Limited's operating margin compare with similar companies?
Poly Medicure Limited's operating margin (16.68%) is higher than that of 3 of the 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.